BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34478523)

  • 1. A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency.
    Fujii Y; Taniguchi M; Nagaya S; Ueda Y; Hashizume C; Watanabe K; Takeya H; Kosaka T; Okazaki T
    Blood Adv; 2021 Oct; 5(20):4265-4277. PubMed ID: 34478523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
    Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
    J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
    Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
    Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus.
    Taniguchi M; Tasaki T; Ninomiya H; Ueda Y; Kuremoto KI; Mitsutake S; Igarashi Y; Okazaki T; Takegami T
    Sci Rep; 2016 Nov; 6():37829. PubMed ID: 27892528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
    Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice.
    Lu MH; Takemoto M; Watanabe K; Luo H; Nishimura M; Yano M; Tomimoto H; Okazaki T; Oike Y; Song WJ
    J Physiol; 2012 Aug; 590(16):4029-44. PubMed ID: 22641779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
    Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
    J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
    Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
    J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation.
    van Kruchten R; Mattheij NJ; Saunders C; Feijge MA; Swieringa F; Wolfs JL; Collins PW; Heemskerk JW; Bevers EM
    Blood; 2013 Mar; 121(10):1850-7. PubMed ID: 23303820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels.
    Hayashi Y; Nemoto-Sasaki Y; Matsumoto N; Hama K; Tanikawa T; Oka S; Saeki T; Kumasaka T; Koizumi T; Arai S; Wada I; Yokoyama K; Sugiura T; Yamashita A
    J Biol Chem; 2018 Nov; 293(45):17505-17522. PubMed ID: 30242129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane sphingomyelin modulates thymocyte development by inhibiting TCR-induced apoptosis.
    Toshima K; Nagafuku M; Okazaki T; Kobayashi T; Inokuchi JI
    Int Immunol; 2019 Mar; 31(4):211-223. PubMed ID: 30561621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
    Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling.
    Brooks MB; Catalfamo JL; MacNguyen R; Tim D; Fancher S; McCardle JA
    J Thromb Haemost; 2015 Dec; 13(12):2240-52. PubMed ID: 26414452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells.
    Tafesse FG; Huitema K; Hermansson M; van der Poel S; van den Dikkenberg J; Uphoff A; Somerharju P; Holthuis JC
    J Biol Chem; 2007 Jun; 282(24):17537-47. PubMed ID: 17449912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation.
    Yang H; Kim A; David T; Palmer D; Jin T; Tien J; Huang F; Cheng T; Coughlin SR; Jan YN; Jan LY
    Cell; 2012 Sep; 151(1):111-22. PubMed ID: 23021219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid-induced pro-thrombotic phosphatidylserine exposure and ionophore-induced microvesiculation is mediated by the scramblase TMEM16F in erythrocytes.
    Öhlinger T; Müllner EW; Fritz M; Sauer T; Werning M; Baron DM; Salzer U
    Blood Cells Mol Dis; 2020 Jul; 83():102426. PubMed ID: 32222693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction.
    Taniguchi M; Ueda Y; Matsushita M; Nagaya S; Hashizume C; Arai K; Kabayama K; Fukase K; Watanabe K; Wardhani LO; Hayashi K; Okazaki T
    FASEB J; 2020 Mar; 34(3):3838-3854. PubMed ID: 31970839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity.
    Chiang YP; Li Z; Chen Y; Cao Y; Jiang XC
    J Biol Chem; 2021 Dec; 297(6):101398. PubMed ID: 34774525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.